A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

120 mg LY2784544OngoingActive not recruitingPhase 2Open NCT01594723 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…